(D) | 1. |
¨ººØ³J¥Õ·|³q¹LµÇ¤p²y¦Ó³QµÇ¤pºÞ§l¦¬¡A·íµÇ¤pºÞ¦³¨ü¶Ë®`®É³y¦¨³J¥Õ§¿¡H
|
A. | ·»úCÅé¡]lysozyme¡^¡C |
B. | ¨©¥L-2-·L¤p²y³J¥Õ¡]£]2 microglobulin¡^¡C |
C. | »´Ãì¡]light chain¡^¡C |
D. | ³£·|³q¹L¡C |
E. | ¥þ³¡¤£·|³q¹L¡C |
|
(C) | 2. |
¨x¯f¥½´Á©ö¨Öµo¨xµÇ¯gÔ¸s¡]hepatorenal syndrome¡^¡A¦¹¯g¤§»F¦]»P¤U¦C¨ººØª¬ªpµLÃö¡H
|
A. | ¥X¦å¡C |
B. | ¨Ï¥Î§Q§¿¾¯¡]diuretics¡^¡C |
C. | ¨Ï¥Î¦åºÞ¦¬ÁY¾¯¡]systemic vasoconstrictors¡^¡C |
D. | ¨Ï¥Î§í¨îcyclooxygenase¤§ßÓª«¡C |
E. | ©â¸¡¤ô¡C |
|
(E) | 3. |
45·³¤k©Ê¡A¦å¹[2.5 mEq/L¡A¦åÀ£120/80 mmHg¡A¨ä§¿¹[±Æªn¬°35 mmole/L¡A¦Ó¦å²M«ºÒ»Ä®Ú¡]HCO3-¡^¬°18 mEq/L¡A¨ä³Ì¥i¯à¤§ì¦]¬°¦ó¡H
|
A. | ¥Ö½èîÇତÀªc¹L¦h¯g¡]Hyperaldosteronism¡^¡C |
B. | ¥Ì¯ó¡]Licorice¡^¨Ï¥ÎªÌ¡C |
C. | ¤ÀªcµÇ¯À¤§¸~½F¡]Renin- secreting tumor¡^¡C |
D. | ¤U®ø¤Æ¹D³à¥¢¹[¡C |
E. | µÇ¤pºÞ»Ä¤Æ¯g¡]Renal tubular acidosis¡^¡C |
|
(B) | 4. |
«æ©ÊµÇ°IºÜ¤§¥NÁ©ʻĤ¤¬r¡A¨äªvÀø¥Ø¼Ð¬°ºû«ù¦å²M«ºÒ»Ä®ÚHCO3-©ó¦h¤Ö¥H¤W¡H¡]¾Ü¤@³Ì¾A·í¤§µª®×¡^
|
A. | 20 mmol/L¡C |
B. | 15 mmol/L¡C |
C. | 10 mmol/L¡C |
D. | 5 mmol/L¡C |
E. | ¤£¥²ºÞ¡A¦]¬°¤£¤Ó«n¡C |
|
(C) | 5. |
¦]§¿¬r¯g±µ¨ü³zªR¯f¤Hµo¥Í°©¯fÅÜ¡An°Ï§OÅnª¬ÅÖºû¤Æ°©ª¢¡]osteitis fibrosa cystica¡^©Î¾T¡]aluminum¡^¤Þ°_¤§°©¯fÅÜ¡A¥i¥H§Q¥Î¤U¦C¨º¤@ºØ²üº¸»X¤§°ª§C§@¬°°Ñ¦Ò¡H
|
A. | µÇ¯À¡]Renin¡^¡C |
B. | ¥Òª¬¸¢²üº¸»X¡]Thyroid hormone¡AT3¡AT4¡^¡C |
C. | °Æ¥Òª¬¸¢²üº¸»X¡]PTH¡^¡C |
D. | ¥Ö½è¿E¯À¡]ACTH¡^¡C |
E. | ¥Ö½èîÇଡ]Aldosterone¡^¡C |
|
(E) | 6. |
¨º¤@ºØ²ÓM¨Ã¤£°Ñ»PµÇµ·²y¡]glomerulus¡^¤§§K¬Ì¶Ë®`¡H
|
A. | ¦h§Î®Ö¥Õ¦å²y¡]polymorphonuclear leukocyte¡^¡C |
B. | ³æ®Ö¥Õ¦å²y (Monocytes , Macrophage¡^¡C |
C. | ²O¤Ú²y¡]T²ÓM¡^¡C |
D. | ¦å¤pªO¡C |
E. | ¬õ¦å²y¡C |
|
(B) | 7. |
30·³¤k©Ê¡A¦]µo¿N¤Î¸¡µh¦Ó¤J°|¡A·NÃѤ£¬Æ²M·¡¡AÀˬdµo²{¦å¬õ¯À¡]Hb¡^8.0 g/dl¡A§¿¯À´á¡]BUN¡^42 mg/dl¡A¦Ù»ÄÓþ¡]creatinine¡^2.5 mg/dl¡A§¿³J¥Õ3+¡A¦å¤pªO70,000/£gl
¡A¦å²G©Ù¤ù¦³¯}¸H¤§¬õ¦å²y¡]fragmented RBC¡^¡A³Ì¦nªºªvÀø¦b¦¹¯f¤H¬°¨º¤@¶µ¡H
|
A. | ¿éª`¦å¤pªO¡C |
B. | ¦å¼ß¤ÀÂ÷³N¡]plasmapheresis¡^¡C |
C. | ¦å²G³zªR¡C |
D. | ¿é¦å¡C |
E. | ¦å²G¹LÂoªk¡]hemofiltration¡^¡C |
|
(A) | 8. |
72·³¤k©Ê¡A©ü°g¦Ó³Q°e¤J°|¡A¨ä¦å²M¶u³Qµo²{¬°102 mEq/L¡A¯f¥v°Ý°_¨Ó¡A®a¤¤¨S¤H·ÓÅU¡A©ü°g¥i¯à¦³´X¤Ñ¤§¤[¤F¡A´£°ª¦å²M¶u®É»Ýª`·N²Ä¤@¤Ñ¤º¡]24¤p®É¤º¡^´£°ª¦å²M¶u¤£¥i¶W¹L¦h¤Ö¡H
|
A. | 12 mEq/L¡C |
B. | 5 mEq/L¡C |
C. | 24 mEq/L¡C |
D. | 18 mEq/L¡C |
E. | ¤£¥²¦Ò¼{¦h¤Ö¡AµLÃöºòn¡C |
|
(B) | 9. |
38·³¤k©Ê¡A¬õ´³©Ê¯T½H¤w¦³¤T¦~¡A§¿¤¤¬õ¦å²y30-50/HPF¡A¨C¤Ñ§¿±Æªn8-10§J³J¥Õ¡A¦å²M¥Õ³J¥Õ1.5 g/dl¡A¥þ¨¤ô¸~¡A¦å²M¦Ù»ÄÓþ¦b¤@Ӥ뤺¥Ñ1.3¤É°ª¨ì4.2 mg/dl¡ABUN¥Ñ25¤É°ª¨ì76 mg/dl¡A¦ý¯f¤H©Ú°µµÇ¬ï¨ë¡A§AÀ³¦Ò¼{¦óªÌ¡H¡]¾Ü¤@³Ì¦X¾Aªºµª®×¡^
|
A. | ¨C¤Ñ¤fªAprednisolone 10 mg¡C |
B. | MethylprednisoloneÀR¯ßª`®g1§J/ ¤Ñ¡Ñ3¦¸¡C |
C. | §Q§¿¾¯Lasix 40 mg/¤Ñ¡C |
D. | ¤fªAprednisolone 40 mg/¤Ñ¡C |
E. | Hydroxychloroquine 400 mg/¤Ñ¡C |
|
(C) | 10. |
°ª¦å¶u¯g¡]hypernatremia¡^¤§ì¦]¦³¨º¨Ç¡H
1.§Ü§Q§¿²üº¸»X¤Àªc¤£·í¯g¡]SIADH¡^¡C
2.¥Òª¬¸¢¾÷¯à§C¤U¡]Hypothyroidism¡^¡C
3.¥Ö½èîÇତÀªc¹L¦h¯g¡]Hyperaldosteronism¡^¡C
4.®wªY¤ó¯g¡]Cushing's Syndrome¡^¡C
|
A. | 1,2¡C |
B. | 1,3¡C |
C. | 3,4¡C |
D. | 2,4¡C |
E. | 1,2,3,4¡C |
|
(C) | 11. |
¦hµo©Ê°©Åè½F¡]Multiple Myeloma¡^·|¨Öµo¤U¦C¨º¨Ç¡H
1.Fanconi syndrome¡C
2.¦å²M³±Â÷¤l»Ø¼W¥[¡]Increased anion gap¡^¡C
3.°ª¦å¶t¡]Hypercalcemia¡^¡C
4.§C¦å²M§¿»Ä¡]Hypouricemia¡^¡C
5.§C¦å¶u¡]Hyponatremia¡^¡C
6.µÇ¯f¯gÔ¸s¡]Nephrotic syndrome¡^¡C
|
A. | 2,3,4,6¡C |
B. | 1,2,3,4¡C |
C. | 1,3,5,6¡C |
D. | 2,3,5,6¡C |
E. | 3,4,5,6¡C |
|
(C) | 12. |
Ãö©ó¬õ´³©Ê¯T½HµÇª¢¡]lupus nephritis¡^¡A¤U¦C½Ñ¶µ¦óªÌ¬°«D¡H
|
A. | Äjº©¼W´Þ©ÊµÇª¢¡]Diffuse proliferative GN¡AClass IV¡^¬Olupus nephritisµÇ«I¥Ç³ÌÄY«ªº¤@«¬¡C |
B. | ¦å²M¾Ç¶EÂ_¥Hanti-ds DNAªº¯S²§©Ê³Ì°ª¡C |
C. | ¦å²M¸ÉÅéÈ¡]complement¡^¦bactive lupus nephritis¤@¯ë³£·|¼W°ª¡C |
D. | Lupus nephritisªº¯f²zÅܤƪº¤ÀÃþ¡]Class¡^¦b¯fµ{¤¤¦³¥i¯àÂà´«¡A¦pClass IV to IIµ¥±¡§Î¡C |
E. | ¶i¤J³zªRªvÀø«á¡A¬õ´³©Ê¯T½H¤§¬¡©Ê³q±`·|°§C¡C |
|
(C) | 13. |
¤@Ó45·³¨k©Ê¯f¤H¡Aserum creatinineȬ°0.9 mg/dl¡ABUN¬°70 mg/dl¡A¨C¤é§¿¶q¬°1500 c.c.¡A³Ì¥i¯àªº±¡ªp¬O¥H¤U¨ººØ¡H
|
A. | ¨x°IºÜ¡]Liver failure¡^¡C |
B. | ºC©ÊµÇª¢¡]Chronic glomerulonephritis¡^¡C |
C. | ¤Q¤G«ü¸z¼ìºÅ¥X¦å¡]Bleeding duodenal ulcer¡^¡C |
D. | «æ©ÊµÇ¤pºÞÃa¦º¡]Acute tubular necrosis¡^¡C |
E. | ¿}§¿¯fµÇ¯fÅÜ¡]Diabetic nephropathy¡^¡C |
|
(B) | 14. |
¦³Ãö§C¹[¦å¯g¡]hypokalemia¡^ªºÁ{§Éªí¼x¡A¤U¦C¦óªÌ¬°«D¡H
|
A. | ¨xµw¤Æ¯f¤H¦X¨Ö¦³§C¹[¦å¯g®É¡A©ö©ó¾ÉP¨x©ü°g¡C |
B. | §C¹[¦å¯g¯f¤H¸û±`¦X¨Ö¦³¥NÁ©ʻĤ¤¬r¡]metabolic acidosis¡^¡C |
C. | ·|¾ÉP¸²µå¿}@¨ü©Ê²§±`¡]glucose intolerance¡^¡C |
D. | ©ö¥[«¤ò¦a¶À¡]digitalis¡^¤¤¬r¡C |
E. | ±`¨Öµo¦³µÇ©Ê§¿±Y¯g¡]nephrogenic diabetes insipidus¡^¡C |
|
(B) | 15. |
¦³ÃöÅã¼v¾¯¡]contrast-medium¡^©Ò¾ÉPªº«æ©ÊµÇ°IºÜ¡]acute renal failure¡^¡A¤U¦C¦óªÌ¬°«D¡H
|
A. | ¸û©öµo¥Í¦bµÇ¥\¯à¤£¥þªº¯f¤H¡C |
B. | §¿²GÀˬd±`¦³¦å§¿¤Î©úÅ㪺¬õ¦å²y¶ê¬W¡]red blood cell cast¡^¡C |
C. | ¨å«¬ªº¯fµ{¬Oµo²{serum creatinine«æÁؤW¤É¡]¦b24-48¤p®É¤º¡^¡A¬ù¤@¶g¤º«K«ì´_¡C
|
D. | Åã¼v¾¯ªº¥Î¶q»PµÇ°IºÜªºµo¥Í¦³¬ÛÃö©Ê¡C |
E. | ¥Ø«e¬ã¨s»{¬°¥i¯à»P¤º¥Ö¯À¡]endothelin¡^¦³Ãö¡C |
|
(D) | 16. |
¦³Ãö§Q§¿¾¯furosemide¡]lasix¡^¡A¤U¦C¦óªÌ¬°«D¡H
|
A. | ¥¦¥Dn§@¥Î¦bµÇ¤pºÞªºthick ascending limb of Henle¡C |
B. | ¥¦ªº°Æ§@¥Î¦³¥i¯à¾ÉPÅ¥¤O»Ùê¡C |
C. | ¥i¯à¤Þ°_§C¦å¹[©ÊÆP¤¤¬r¡]hypokalemic alkalosis¡^¡C |
D. | ¥i¼W¥[§¿¤¤¶tªº±Æªn¡A±`¥Î©óµÇµ²¥ÛªºªvÀø¡C |
E. | ¥Î¦bµÇ¥\¯à¤£¨}ªº¯f¤H¡A¤ñthiazide¸û¦³®Ä¡C |
|
(A) | 17. |
¦³ÃöºC©Ê¹]¤¤¬rµÇ¯fÅÜ¡]lead nephropathy¡^¤§Á{§É¯S¼x¡A¤U¦C¦óªÌ¬°«D¡H
|
A. | ¥Dn²£¥ÍµÇ¤pºÞ¶¡½èµÇ¯f¡]chronic tubulointerstitial renal disease¡^¡A¥½´Á®ÉµÇŦªº¤j¤p·|Åܤj¡C |
B. | ±`¦X¨Ö¦³°ª§¿»Ä¯g¡]hyperuricemia¡^¤Îµh·¡C |
C. | Á{§É¤W±`¦X¨Ö¦³°ª¦åÀ£¯g¡C |
D. | ±`¦X¨Ö¦³Fanconi syndrome¡C |
E. | ÃĪ«ªvÀø¥Dn¾achelating agent¡A¦p calcium disodium edetate¡]EDTA¡^¡C |
|
(B) | 18. |
Ãö©óµÇµ²¥Û¡]nephrolithiasis¡^¡A¤U¦C¦óªÌ¬°«D¡H
|
A. | ¶tµ²¥Û¡]Calcium oxalate and calcium phosphate stones¡^¬O³Ì±`¨£ªºµ²¥Û¡C |
B. | ¨CÓµ²¥Û¯f¤H³£¦³°ª¶t¦å¯g¡]hypercalcemia¡^¡C |
C. | ¨k©Ê¯f¤H¤ñ¤k©Ê¦h¡C |
D. | º¦¸µo§@±`¨£©ó¦~ÄÖ¦b20¦Ü30·³¡C |
E. | ¤º¬ì¹w¨¾¤ÎªvÀø¤è¦¡¬O¼W¥[¤ô¥÷ªºÄá¨ú¤Î¨Ï¥Îthiazide diuretics¡C |
|
(E) | 19. |
Ãö©ó¿}§¿¯fµÇ¯fÅÜ¡]DM nephropathy¡^¡A¤U¦C¦óªÌ¬°«D¡H
|
A. | ¯Ø®q¯À¨Ì¿à«¬¡]IDDM¡^¤Î«D¯Ø®q¯À¨Ì¿à«¬¡]NIDDM¡^¨äµÇ¯fÅܪºÁ{§Éªí¼x¬O¬Û¦üªº¡C |
B. | ¥i¯à¨Öµo²Ä¥|«¬µÇ¤pºÞ»Ä¤¤¬r¡]Type IV RTA¡^¤Î°ª¹[¦å¯g¡C |
C. | ·L¶q¥Õ³J¥Õ§¿¡]microalbuminuria¡^±`¬OµÇ¯fÅܪº¦´Áªí¼x¡C |
D. | Angiotensin-converting enzyme (ACE) inhibitors¯à´î½wµÇ¯fÅܪº¶i¦æ³t«×¡C |
E. | ¿}§¿¯fµÇ¯fÅܯf¤H¤@¯ë»{¬°¤£©y°µµÇ²¾´Ó¡]renal transplantation¡^¡C |
|
(E) | 20. |
Ãö©óA«¬§K¬Ì²y³J¥ÕµÇµ·²yµÇª¢¡]IgA nephropathy¡^¡A¤U¦C¦óªÌ¬°«D¡H
|
A. | µÇŦ¯f²zÀˬdµo²{IgA¥Dn¨H¿n©óµÇµ·²y¶¡½è³¡¦ì¡]mesangial area¡^¡C |
B. | IgA nephropathyªºµo¯f¾÷Âà©|¥¼§¹¥þÁA¸Ñ¡C |
C. | IgA nephropathy±`µo²{¦X¨Ö¦³»øª½©Ê¯á´Õª¢¡]ankylosing spondylitis¡^¡C |
D. | ¦¹¯g±`¦b²¾´ÓµÇ¤W´_µo¡C |
E. | IgA nephropathyªºµÇŦ¤Î§K¬Ì¾Çªºªí¼x»PHenoch-Schonlein purpura§¹¥þ¤£¦P¡C |
|
(C) | 21. |
ªvÀø§¿»Äµ²¥Û¡]uric acid
stones¡^¡A³Ì¨Î¿ï¾Ü¬O 1. Low purine
diet¡C 2.
Hydration¡C 3.ÆP¤Æ§¿²G¨ìpH>6-7¡C
4. ¨Ï¥Î allopurinol¡C
5. ¨Ï¥Î§Q§¿¾¯¡C
|
A. | 1,2,5¡C |
B. | 1,2,3¡C |
C. | 1,2,3,4¡C |
D. | 1,2,3,5¡C |
E. | 1,3,5¡C |
|
(E) | 22. |
§¿¬r¯g±wªÌ¦b±µ¨ü¦å²G³zªRªvÀø«á¡A¤U¦C¨º¨Ç±¡ªp¤´µLªkÀò±oÅãµÛ§ïµ½¡H
1. µÃ·¾ÀG¹D¯gÔ¸s¡]Carpal tunnel syndrome¡^¡C
2. Congestive heart failure¡C
3. Hepatitis¡C
4. Hyperkalemia¡C
5. Hypertriglyceridemia¡C
|
A. | 1,2¡C |
B. | 3,4,5¡C |
C. | 2,4¡C |
D. | 3,5¡C |
E. | 1,3,5¡C |
|